$169 Million is the total value of HealthInvest Partners AB's 14 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 57.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GILD | Buy | GILEAD SCIENCES INC | $24,479,000 | -13.0% | 249,300 | +3.7% | 14.48% | +0.7% |
PFE | Sell | PFIZER INC | $23,903,000 | -15.7% | 761,000 | -10.0% | 14.14% | -2.4% |
LPNT | Buy | LIFEPOINT HEALTH INC | $22,435,000 | +23.8% | 316,430 | +51.8% | 13.27% | +43.3% |
CRL | Buy | CHARLES RIV LABS INTL INC | $21,617,000 | +27.9% | 340,320 | +41.6% | 12.78% | +48.0% |
ANTM | Sell | ANTHEM INC | $14,588,000 | -47.9% | 104,200 | -39.0% | 8.63% | -39.7% |
MGLN | Buy | MAGELLAN HEALTH INC | $14,436,000 | -14.0% | 260,442 | +8.8% | 8.54% | -0.4% |
VAR | New | VARIAN MED SYS INC | $14,018,000 | – | 190,000 | +100.0% | 8.29% | – |
GTS | Buy | TRIPLE-S MGMT CORPcl b | $12,752,000 | -25.1% | 715,981 | +7.9% | 7.54% | -13.3% |
SUPN | New | SUPERNUS PHARMACEUTICALS INC | $10,982,000 | – | 782,746 | +100.0% | 6.50% | – |
AIQ | ALLIANCE HEALTHCARE SRVCS IN | $5,119,000 | -47.8% | 524,538 | 0.0% | 3.03% | -39.5% | |
SSRG | Buy | SYMMETRY SURGICAL INC | $1,580,000 | +59.6% | 177,581 | +56.5% | 0.93% | +84.6% |
ANIK | New | ANIKA THERAPEUTICS INC | $1,299,000 | – | 40,800 | +100.0% | 0.77% | – |
OSUR | New | ORASURE TECHNOLOGIES INC | $1,228,000 | – | 276,603 | +100.0% | 0.73% | – |
ICCC | IMMUCELL CORP | $647,000 | -24.2% | 108,750 | 0.0% | 0.38% | -12.2% | |
BASI | Exit | BIOANALYTICAL SYS INC | $0 | – | -320,234 | -100.0% | -0.33% | – |
CRY | Exit | CRYOLIFE INC | $0 | – | -90,000 | -100.0% | -0.52% | – |
SURG | Exit | SYNERGETICS USA INC | $0 | – | -332,687 | -100.0% | -0.80% | – |
AET | Exit | AETNA INC NEW | $0 | – | -215,900 | -100.0% | -14.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-10-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
MCKESSON CORP | 14 | Q3 2022 | 14.6% |
ANTHEM INC | 12 | Q4 2017 | 14.3% |
TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR | 2024-01-30 |
13F-HR | 2023-02-14 |
13F-HR | 2022-10-21 |
13F-HR | 2022-07-08 |
13F-HR | 2022-05-05 |
13F-HR | 2022-01-18 |
13F-HR | 2021-11-08 |
13F-HR | 2021-08-10 |
13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.